dimenhydrinate Syrup 12.5 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
Malaysia
Manufacturer #20939
Established in 1981, this Manufacturer is a CTD dossier owner and manufacturer with a global reach spanning over 40 countries and regions. Operating as a GMP manufacturer, it holds certifications including cGMP and ISO 9001:2000, ensuring adherence to international quality standards. The Manufacturer's production lines are equipped to handle a diverse range of products, including tablets, capsules, creams, balms, external liquids, and powder sachets. With a dedicated team of professionals, it continues to uphold its reputation as a reliable CTD dossier owner and manufacturer and GMP manufacturer, committed to delivering high-quality healthcare solutions worldwide.
Manufacturer usually replies in 8 days
Dimenhydrinate is a pharmaceutical drug that is used to treat insomnia, vertigo and nausea. As a standalone drug, it is primarily marketed as dimenhydrinate tablets but is also available in liquid and suppository form. Depending on the formulation, it is can be administered orally, or by way of either intravenous or intramuscular injection.
Dimenhydrinate is also commonly used as an ingredient in combination drugs, along with substances such as cinnarizine, pyridoxine, paracetamol, and others. Major suppliers of trade name dimenhydrinate medications include Pfizer, Sandoz, and Teva. On the other hand, suppliers Fresenius Kabi, Mylan are few of the distributors of generic versions of the drug.
Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.